ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1714

The Circadian Clock Gene Bmal1 Negatively Regulates Autoantibody Production in SLE

Shuichiro Nakabo1, Donavon Sandoval-Heglund1, Victoria Hoffmann2, Mingzeng Zhang1, Norio Hanata1, Zerai Manna1, Elaine Poncio1, Sarfaraz Hasni3 and Mariana Kaplan4, 1NIAMS/NIH, Bethesda, MD, 2ORS/ORF/NIH, Bethesda, MD, 3National Institutes of Health, Bethesda, MD, 4National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

Meeting: ACR Convergence 2022

Keywords: Animal Model, Autoantibody(ies), neutrophils, sleep, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: SLE – Animal Models Poster

Session Type: Poster Session D

Session Time: 1:00PM-3:00PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that affects multiple organs including kidney and skin. While its etiology and pathogenesis are still largely unknown, recent studies suggest significant involvement of neutrophils. Dysregulation of neutrophil functions has been proposed to trigger and perpetuate autoimmunity. Specifically, evidence suggests a role for neutrophil extracellular traps (NETs; the extrusion of nucleic acids and various antibacterial components by the neutrophils as a process of program cell death) in autoimmunity. Neutrophils also synthesize various cytokines including type I interferons (IFNs), B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), which may be involved in the induction of proinflammatory responses in SLE.

The number and phenotype of neutrophils in circulation displays circadian oscillations. A recent study showed that this is influenced by one of the clock genes, brain and muscle aryl hydrocarbon receptor nuclear translocator-like 1 (Bmal1). Neutrophils that lack Bmal1 are defective in aging and more responsive to sterile tissue inflammation. Therefore, in this study, we hypothesized that Bmal1 plays a protective role in SLE and investigated its association with SLE using TLR7-induced murine lupus model and human peripheral blood neutrophils from lupus patients.

Methods: Myeloid conditional Bmal1 knockout mice (KO) and C57BL/6J mice (WT) were treated with imiquimod cream (IMQ) for 6 weeks to induce a lupus phenotype. Upon euthanasia, systemic inflammatory reactions, serum anti-dsDNA antibody, histological findings in each organ, immune complex (IC) deposition in kidney, proteinuria, and type I IFN responses were evaluated. Mouse neutrophils were obtained from bone marrow using negative selection beads and their NET-forming capacity and gene expression were evaluated. Human peripheral neutrophils were purified from SLE patients in the morning (7am – 11am) to assess gene responses.

Results: KO and WT treated with IMQ showed comparable levels of splenomegaly, anemia, thrombocytopenia, and local skin inflammation. Histological changes in glomeruli were minimal and prominent proteinuria was not observed in either group. However, serum anti-dsDNA antibody levels were higher, and more IC deposition in kidney was observed in KO mice. The expression levels of IFN-stimulated genes in kidney were higher in KO. More neutrophils infiltrated into skin lesions in KO. There was no difference in NET-forming capacity of bone marrow neutrophils and serum cell-free DNA level between the two groups of mice. NET formation in tissue was not different either. The expression levels of APRIL in bone marrow neutrophils and the percentage of B cells in spleen were significantly higher in KO. Bmal1 expression level in human peripheral blood neutrophils from SLE patients correlated with serum C3 level and inversely correlated with serum anti-dsDNA antibody level.

Conclusion: Bmal1 negatively regulates autoantibody production and immune complex deposition in TLR7-induced murine lupus model. These results indicate that perturbation in the circadian rhythm of neutrophils can have pathogenic consequences in SLE.


Disclosures: S. Nakabo, None; D. Sandoval-Heglund, None; V. Hoffmann, None; M. Zhang, None; N. Hanata, GlaxoSmithKlein(GSK); Z. Manna, None; E. Poncio, None; S. Hasni, None; M. Kaplan, None.

To cite this abstract in AMA style:

Nakabo S, Sandoval-Heglund D, Hoffmann V, Zhang M, Hanata N, Manna Z, Poncio E, Hasni S, Kaplan M. The Circadian Clock Gene Bmal1 Negatively Regulates Autoantibody Production in SLE [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/the-circadian-clock-gene-bmal1-negatively-regulates-autoantibody-production-in-sle/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-circadian-clock-gene-bmal1-negatively-regulates-autoantibody-production-in-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology